Insights

Has there been a shift in how the European courts approach preliminary injunctions?

作者 Dr Paul England 以及 Christoph de Coster, LL.M. (UC Davis)

AI driven drug design

Unpacking the role of AI in bringing new drugs to market.

作者 Dr Paul England

1 / 6 观点

The EU torpedoes itself in cross-border patent disputes

作者 Dr Paul England

Edison Open House Global Healthcare 2021 – key takeaways from our panel

作者

Will the UK government's COVID-19 dosing regime gamble pay off?

作者 Alison Dennis 以及 Justyna Ostrowska

What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies

作者 Alison Dennis

8+2+1 plus what? How UK data and market exclusivity rights will be affected from 1 January 2021

作者 Alison Dennis 以及 Dr Paul England

SPC for ezetimibe/simvastatin considered invalid in preliminary relief proceedings

Targeted treatments – Part 3: the power of orphan drug protection

作者 Dr Paul England

German Federal Court of Justice invalidates Truvada SPC

作者 Dr. Nora E. Wessendorf, LL.M. (Washington)

Targeted treatments – Part 1: Targeted treatments: patents for particular populations

作者 Dr Paul England

CJEU ruling to liberalise parallel import in Poland